Literature DB >> 9204220

Comparing compliance patterns between randomized treatments.

B Vrijens1, E Goetghebeur.   

Abstract

When two equally efficacious drugs enter the market, the one with the better compliance is likely to be more widely used. Special management of the delivery may produce increased compliance. In this paper we analyze a trial of a single drug dosing prescription with patients randomized to either daily self monitoring of the outcome (blood pressure) or not. The study used Medication Event Monitoring Systems (MEMS) to record each exact time and date when a patient opened the pill container. No established method is available for comparing these high-dimensional compliance patterns between groups. This paper investigates several summary measures that highlight different dimensions of the pattern and the drug context in which they may be meaningful. Further, we examine conditional and marginal models that enable comparisons of the full pattern of daily dosing indicators for subjects between the groups. We found no simple difference in average compliance levels, but we found an interesting interaction between treatment and time: similar compliance existed initially among patients in both randomized groups, with a stronger decline over time for patients who did not monitor their blood pressure. We discuss how a balance between simplicity of interpretation and efficiency of data use may be sought in this case.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9204220     DOI: 10.1016/s0197-2456(96)00235-8

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  30 in total

1.  The formulation of the principle of superposition in the presence of non-compliance and its applications in multiple dose pharmacokinetics.

Authors:  W Wang; S P Ouyang
Journal:  J Pharmacokinet Biopharm       Date:  1998-08

2.  Home blood pressure teletransmission for better diagnosis and treatment.

Authors:  T G Pickering; W Gerin; J K Holland
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

Review 3.  Modeling and simulation of adherence: approaches and applications in therapeutics.

Authors:  Leslie A Kenna; Line Labbé; Jeffrey S Barrett; Marc Pfister
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

4.  Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics.

Authors:  Laetitia Comté; Bernard Vrijens; Eric Tousset; Paul Gérard; John Urquhart
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-05-12       Impact factor: 2.745

5.  Estimation of tenofovir's population pharmacokinetic parameters without reliable dosing histories and application to tracing dosing history using simulation strategies.

Authors:  Ayyappa Chaturvedula; Michael J Fossler; Craig W Hendrix
Journal:  J Clin Pharmacol       Date:  2013-11-30       Impact factor: 3.126

6.  Development of an algorithm for analysing the electronic measurement of medication adherence in routine HIV care.

Authors:  Aurélie Rotzinger; Matthias Cavassini; Olivier Bugnon; Marie Paule Schneider
Journal:  Int J Clin Pharm       Date:  2016-07-29

Review 7.  Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens.

Authors:  J Urquhart
Journal:  Pharmacoeconomics       Date:  1999-03       Impact factor: 4.981

8.  Effects of daily adherence to antihypertensive medication on blood pressure control.

Authors:  Adam J Rose; Mark E Glickman; Meredith M D'Amore; Michelle B Orner; Dan Berlowitz; Nancy R Kressin
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-02-16       Impact factor: 3.738

9.  Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients.

Authors:  R M Savic; A Barrail-Tran; X Duval; G Nembot; X Panhard; D Descamps; C Verstuyft; B Vrijens; A-M Taburet; C Goujard; F Mentré
Journal:  Clin Pharmacol Ther       Date:  2012-10-03       Impact factor: 6.875

Review 10.  Adherence and its measurement in phase 2/3 microbicide trials.

Authors:  Elizabeth E Tolley; Polly F Harrison; Els Goetghebeur; Kathleen Morrow; Robert Pool; Doug Taylor; Stephanie N Tillman; Ariane van der Straten
Journal:  AIDS Behav       Date:  2010-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.